Recently, a new study challenged this claim by demonstrating that higher CD276 expression on tumor cells positively correlated with increased number of CD8+ T cell and plasmacytoid dendritic cells (pDCs) in patients suffering from non-small cell lung cancer (NSCLC)24. The gene discussed is CD276; the disease is neoplasm.